Avalon Ventures
Avalon Ventures is a private, early-stage venture capital firm founded in 1980 that forms and finances seed-stage companies in life sciences and information technology through multiple fund vintages and an embedded Accelerator program, serving passionate entrepreneurs pursuing disruptive ideas.
- Company typePrivate
- Founded1980
- HeadquartersLa Jolla, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Avalon Ventures does
Avalon Ventures, LLC is a private, early-stage venture capital firm founded by Kevin Kinsella, operating from offices in La Jolla, California and Cambridge, Massachusetts. The firm focuses on seed and early-stage company formation and financing across two sectors: life sciences (biotechnology and pharmaceuticals) and information technology (wireless, software, media technology, and internet infrastructure). Avalon's investment vehicle is a series of at least eight fund vintages (Avalon V through Avalon VIII), and the firm additionally runs an Accelerator program that embeds CFO and operational services into portfolio companies rather than providing capital alone.
Avalon does not develop proprietary technology products; its offering to entrepreneurs consists of equity capital, company formation expertise, board-level governance, and operational support. The firm differentiates itself through a team of former entrepreneurs and operating executives — including founder Kevin Kinsella (125+ companies formed), Managing Director Jay Lichter Ph.D. (25 investments, $6B+ in biotech transactions, 250+ patents), Director Brady Bohrmann (75+ companies across IT and biotech), Director Steve Tomlin (wireless/IT/media), and Partner Rich Levandov (former Phoenix Technologies co-founder and AOL VP) — alongside CFO Tighe Reardon, who serves as CFO of the Accelerator and its portfolio companies.
Avalon earns revenue through traditional venture capital economics: management fees charged on assets under management across its fund vintages and carried interest realized from successful portfolio company exits. Documented exits include Vertex Pharmaceuticals, Onyx Pharmaceuticals, Synaptics, Vocera Communications, Amira Pharmaceuticals (acquired by Bristol-Myers Squibb), Synthorx (acquired by Sanofi), PersonaLogic (acquired by AOL), XenoPharm (acquired by Deltagen), and Sytera (acquired by Sirion Therapeutics). Marketing and deal sourcing rely on founder/entrepreneur networks and industry event participation rather than outbound sales channels, consistent with a sales-led relationship-driven GTM motion targeting passionate entrepreneurs pursuing disruptive ideas in changing market environments.
Avalon Ventures firmographics
Firmographics- Name
- Avalon Ventures
- Legal name
- Avalon Ventures, LLC
- Website
- https://avalon-ventures.com
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Avalon Ventures is a private, early-stage venture capital firm founded in 1980 that forms and finances seed-stage companies in life sciences and information technology through multiple fund vintages and an embedded Accelerator program, serving passionate entrepreneurs pursuing disruptive ideas.
- Ownership category
- akta.pro rank
Avalon Ventures industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
- akta.pro secondary industry
- Accelerators & Incubators (Investor-Operated) (FSANAAAM)
Keywords
Where Avalon Ventures is headquartered
LocationHeadquarters
- HQ city
- La Jolla
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Avalon Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Management fees and carried interest: Venture capital revenue is generated through management fees charged on assets under management and carried interest (performance fees) from successful portfolio company exits, including IPOs and acquisitions.
Go-to-market motion1 record
Marketing channels2 records
Avalon Ventures product offering
Product offeringCore offering
Avalon Ventures is an early-stage venture capital firm that forms and finances seed and early-stage companies in the life sciences and information technology sectors. It deploys capital through successive investment funds (Avalon V through Avalon VIII) and supplements investments with an Accelerator program providing CFO services and operational support to portfolio companies.
Product overview
Avalon Ventures is a venture capital firm specializing in seed and early-stage company investments across life sciences and information technology sectors. The firm operates through investment funds (Avalon V through Avalon VIII) and an Accelerator program. The investment strategy focuses on disruptive ideas in changing market environments, with team members specializing in different sectors including biotechnology, pharmaceuticals, wireless technology, IT, and media technology. The Accelerator program provides CFO services and operational support to portfolio companies. As a VC firm, Avalon Ventures does not offer a traditional product; its offering consists of capital investment, mentorship, and operational support to early-stage companies rather than a commercial product or service.
Differentiator
Problem solved
Functional benefit
Products and services
- Avalon Ventures Investment Funds (Avalon V through Avalon VIII) Seed and early-stage equity investment funds for entrepreneurs and startups in life sciences and information technology sectors. Each fund is structured as a venture capital vehicle investing in exchange for equity ownership in portfolio companies.
- Avalon Accelerator Program
Quantifiable outcome
- 125+ early-stage companies formed and financed over 30+ years
- +2 more outcomes
Companies that use Avalon Ventures
Customer profileSegments1 record
Ideal customer profiles2 records
Avalon Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Avalon Ventures partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights4 records
Avalon Ventures competitors and assessment
Company assessmentDirect peers
- Atlas Venture: Early-stage venture capital firm focused exclusively on life sciences, operating an incubator-style model that forms and finances biotech startups. Direct peer to Avalon in life-sciences company formation, sector focus, and seed/Series A stage.
- 5AM Ventures: Early-stage life sciences venture capital firm focused on formation and Series A investing in biotech and platform companies. Comparable to Avalon in its emphasis on company creation, sector specialization, and seed-stage focus in therapeutics.
- Versant Ventures: Healthcare-focused venture capital firm investing across biotech, medical devices, and healthcare services with significant company-formation activity. Overlaps with Avalon's life-sciences company-creation model and biotech investment stage.
- ARCH Venture Partners: Early-stage venture firm that co-founds and builds technology and life-sciences companies from inception. Strong overlap with Avalon in deep-tech and biotech formation, and in providing early operational and capital support.
- Frazier Healthcare Partners: Healthcare-dedicated venture capital firm investing across life sciences and healthcare services from seed to growth. Comparable to Avalon in life-sciences focus, though typically with larger fund sizes and broader stage range.
- SV Health Investors: Healthcare-focused venture capital firm with deep biotech company-creation capabilities through its incubator model. Directly comparable to Avalon's life-sciences company-formation and early-stage investing model.
- Masthead Venture Partners: Early-stage venture capital firm co-founded by Brady Bohrmann (now at Avalon) in 1997, focused on IT and biotech. Direct peer in early-stage sector focus and stage, and shares team lineage with Avalon.
Broad incumbents
- New Enterprise Associates (NEA): Large multi-stage venture firm with significant life-sciences and technology practices. Represents the broader-incumbent category: Avalon competes for the same biotech and IT deals but NEA operates at meaningfully larger fund sizes and broader stages.
- Andreessen Horowitz (a16z): Mega-fund venture firm with dedicated bio/health and IT funds competing for the same founder relationships. Avalon is a smaller, more specialist alternative to a16z's broader bio+tech offering.
Emerging players
- Lux Capital: Early-stage venture firm investing in science and technology-driven companies, including biotech and deep tech. Comparable to Avalon's IT and life-sciences seed focus, though typically invests at slightly later stages and with larger initial checks.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Avalon Ventures social profiles
Digital presenceAvalon Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avalon Ventures leadership team
Management profileNumber of profiles
Profiles6 records
Avalon Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avalon Ventures M&A and investment
M&A and investmentM&A
Investments191 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avalon Ventures
What does Avalon Ventures do?
Avalon Ventures is an early-stage venture capital firm that forms and finances seed and early-stage companies in the life sciences and information technology sectors. It deploys capital through successive investment funds (Avalon V through Avalon VIII) and supplements investments with an Accelerator program providing CFO services and operational support to portfolio companies.
Is Avalon Ventures a public or private company?
Avalon Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Avalon Ventures founded?
Avalon Ventures was founded in 1980. It employs 11 to 50 people.
Where is Avalon Ventures based?
Avalon Ventures is headquartered in La Jolla, United States, in the North America region.
How does Avalon Ventures make money?
One revenue line is on record: management fees and carried interest.
Who are Avalon Ventures's main competitors?
Direct peers on record are Atlas Venture, 5AM Ventures, Versant Ventures, ARCH Venture Partners, Frazier Healthcare Partners, SV Health Investors and Masthead Venture Partners. Broad incumbents are New Enterprise Associates (NEA) and Andreessen Horowitz (a16z). Lux Capital is listed as an emerging player.
Does Avalon Ventures have an API?
No public API is recorded for Avalon Ventures.
What industry is Avalon Ventures in?
Avalon Ventures's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists), with a secondary code of FSANAAAM, Accelerators & Incubators (Investor-Operated). Its NAICS code is 523940 and its SIC code is 6282.